Insect growth regulator.
Registry Numbers and Inventories.
Agricultural Chemical and Pesticide
Swiss Giftliste 1
Melting point, °C
Boiling point, °C
1.35 g/cm3 (20 C)
Solubility in water
11 g/L (20 C)
Partition coefficient, pKow
Hazards and Protection.
Store in well-ventilated, secure area out of reach of children and animals.
All chemicals should be considered hazardous. Avoid direct physical contact. Use appropriate, approved safety equipment. Untrained individuals should not handle this chemical or its container. Handling should occur in a chemical fume hood.
Safety glasses or goggles, rubber gloves, waterproof boots, long-sleeved shirt, long pants and hat.
Use NIOSH/MSHA approved respirator appropriate for exposure of concern.
Evacuate area and ventilate. Wear protective equipment. If required, use an inert absrobent. Sweep up and place in an appropriate container for disposal. Wash contaminated surfaces.
No hydrolysis was observed < or = 70 C for 28 days. Stable < 310 C.
Dry chemical, foam or carbon dioxide
Coma was reported following ingestion of an herbicide containing atrazine, aminotriazole, ethylene glycol, and formaldehyde. Muscle tremors, tetany, and ataxia have been reported in animals following ingestions of triazine herbicides.
Seek medical attention. If individual is drowsy or unconscious, do not give anything by mouth; place individual on the left side with the head down. Contact a physician, medical facility, or poison control center for advice about whether to induce vomiting. If possible, do not leave individual unattended.
If symptoms develop, move individual away from exposure and into fresh air. If symptoms persist, seek medical attention. If breathing is difficult, administer oxygen. Keep person warm and quiet; seek immediate medical attention.
Remove contaminated clothing and wash exposed area thoroughly with soap and water. A physician should examine the area if irritation or pain persists.
Irrigate exposed eyes with copious amounts of tepid water for at least 15 minutes. If irritation, pain, swelling, lacrimation, or photophobia persist, the patient should be seen in a health care facility.